These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20510001)

  • 1. [The relationship between FHIT and WWOX expression and clinicopathological features in hepatocellular carcinoma].
    Lin J; Wang B; Huang AM; Wang XJ
    Zhonghua Gan Zang Bing Za Zhi; 2010 May; 18(5):357-60. PubMed ID: 20510001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of fragile histidine triad (FHIT) and WW-domain oxidoreductase gene (WWOX) in nasopharyngeal carcinoma.
    Chen X; Li P; Yang Z; Mo WN
    Asian Pac J Cancer Prev; 2013; 14(1):165-71. PubMed ID: 23534718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland.
    Dincer N; Tezel GG; Sungur A; Himmetoglu C; Huebner K; Güler G
    Oral Oncol; 2010 Mar; 46(3):195-9. PubMed ID: 20060354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathological significance of aberrant methylation of the fragile histidine triad gene in patients with hepatocellular carcinoma].
    Sun Y; Geng XP; Zhu LX; Xiong QR; Qian YB; Dong GY; Li XM
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):609-12. PubMed ID: 16784654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of WWOX and FHIT is downregulated by exposure to arsenite in human uroepithelial cells.
    Huang YC; Hung WC; Chen WT; Yu HS; Chai CY
    Toxicol Lett; 2013 Jul; 220(2):118-25. PubMed ID: 23618899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordant loss of fragile gene expression early in breast cancer development.
    Guler G; Uner A; Guler N; Han SY; Iliopoulos D; McCue P; Huebner K
    Pathol Int; 2005 Aug; 55(8):471-8. PubMed ID: 15998374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features.
    Bloomston M; Kneile J; Butterfield M; Dillhoff M; Muscarella P; Ellison EC; Melvin WS; Croce CM; Pichiorri F; Huebner K; Frankel WL
    Ann Surg Oncol; 2009 Aug; 16(8):2331-8. PubMed ID: 19434452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis.
    Nan KJ; Ruan ZP; Jing Z; Qin HX; Wang HY; Guo H; Xu R
    World J Gastroenterol; 2005 Jan; 11(2):228-31. PubMed ID: 15633221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma.
    Guler G; Uner A; Guler N; Han SY; Iliopoulos D; Hauck WW; McCue P; Huebner K
    Cancer; 2004 Apr; 100(8):1605-14. PubMed ID: 15073846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
    Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
    Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss expression of active fragile sites genes associated with the severity of breast epithelial abnormalities.
    Wang TT; Frezza EE; Ma R; Hu SY; Liu CZ; Zhang GY; Wachtel MS; Lü XM; Feng JB; Lü CX
    Chin Med J (Engl); 2008 Oct; 121(20):1969-74. PubMed ID: 19080258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer.
    Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K
    Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fhit and Wwox loss-associated genome instability: A genome caretaker one-two punch.
    Schrock MS; Karras JR; Guggenbiller MJ; Druck T; Batar B; Huebner K
    Adv Biol Regul; 2017 Jan; 63():167-176. PubMed ID: 27773744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and Prognostic Role of FHIT, Fibronectin, and PTEN in Hepatocellular Carcinoma.
    Zhang MJ; Yan Q; Zhang GL; Wie YH; Yuan WB; Xu W; Huang LF
    Clin Lab; 2016 Jul; 62(7):1255-1264. PubMed ID: 28164627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
    Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
    J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression and significance of WWOX and β-catenin in hepatocellular carcinoma.
    Li YP; Wu CC; Chen WT; Huang YC; Chai CY
    APMIS; 2013 Feb; 121(2):120-6. PubMed ID: 23030478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity.
    Cantor JP; Iliopoulos D; Rao AS; Druck T; Semba S; Han SY; McCorkell KA; Lakshman TV; Collins JE; Wachsberger P; Friedberg JS; Huebner K
    Int J Cancer; 2007 Jan; 120(1):24-31. PubMed ID: 17019711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragile histidine triad gene alterations are not essential for hepatocellular carcinoma development in South Korea.
    Nam CW; Shin JW; Park NH
    World J Gastroenterol; 2008 Jun; 14(22):3526-33. PubMed ID: 18567082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity and methylation of multiple tumor suppressor genes on chromosome 3 in hepatocellular carcinoma.
    Zhang X; Li HM; Liu Z; Zhou G; Zhang Q; Zhang T; Zhang J; Zhang C
    J Gastroenterol; 2013 Jan; 48(1):132-43. PubMed ID: 22766745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk.
    Lee HL; Cheng HL; Liu YF; Chou MC; Yang SF; Chou YE
    PLoS One; 2017; 12(4):e0176141. PubMed ID: 28426730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.